Diabetes

Jardiance and Synjardy approved as an addition to diet and exercise to improve blood sugar control in children aged 10 years and older with type 2 diabetes.

A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.

Stormi Gale, PharmD, BCCP, a cardiology pharmacy specialist at Novant Health, discussed the important role of SGLT2 inhibitors in glycemic control.

Pharmacists should learn the basics of this leading cause of vision loss among adults worldwide.

Levels of troponin were higher in people who had type 2 diabetes for a longer period than people with healthy blood levels.

The proportion of participants with cytomegalovirus disease was 10% with letermovir and 12% with valganciclovir.

Available pharmacological therapies have shown high efficacy in achieving weight loss.

Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.

Patients who did not have health care coverage were found to have a significantly higher mean HbA1c levels among adults with diabetes.

Options abound, but pharmacists should address barriers to prevent inequities for patients when they seek treatment.

BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.

Having scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.

Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.

Pharmacists will play a growing role in the use of biosimilars and guiding patients through the switching process.

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.

Screening tools are becoming widely used to help clinicians address the needs of patients with diabetes to improve health outcomes.

Nearly 18-times more patients on trizepatide 15 mg achieved a body weight reduction of 15% or more compared to placebo.

Risk of incident diabetes was markedly higher among males and in those with more severe COVID-19.

Tzield does not have any known contraindications.

Prediagnostic weight loss could be an important marker for colorectal cancer diagnosis.

The results of a review, published in Cureus, show that the medications reduced the risk of HF.

A severe reduction in food intake lasting just 2 weeks caused damage to the heart and kidneys that appeared to be irreversible, even after the body weight was restored.

Data from the aflibercept 8 mg clinical trial program will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, April 23 to 27.

Findings show that study participants experienced improvements in both blood sugar control and the lipid profile.

A linear mixed-effect model for repeated estimated glomerular filtration rate measurements at baseline and a follow-up visit, up to 5 years after baseline, shows results.